Zura Bio Inc

This study is testing an investigational drug called tibulizumab for adults with moderate-to-severe hidradenitis suppurativa (HS), a chronic inflammatory skin condition. For the first 16 weeks, participants will be randomly assigned to receive either the drug or a placebo. Then, …

This study is testing whether an investigational drug called tibulizumab can help control systemic sclerosis, a rare autoimmune disease that causes skin thickening and can damage internal organs like the lungs. For the first 24 weeks, some participants will receive the drug while…